Vivek D. Bobade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vivek D. Bobade has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Pravin Chimaji Mhaske
Department of Chemistry, Government College Daman (Veer Narmad South Gujarat University, Surat), Daman 396210, UT of DNH & DD, India
10 shared publications Shivaji H. Shelke
Post Graduate Department of Chemistry, H. P. T. Arts and R. Y. K. Science College Savitribai Phule Pune University College Road 422 005 Nashik India
6 shared publications- Abhijit P. Chavan
Department of Chemistry S. P. Mandali's Sir Parashurambhau College (Affiliated to Savitribai Phule Pune University) Pune India
4 shared publications Abhijit Shinde
Department of Chemistry S. P. Mandali's Sir Parashurambhau College (Affiliated to Savitribai Phule Pune University) Pune India
4 shared publications- Abraham Vidal-Limon
Red de Estudios Moleculares Avanzados, Clúster Científico y Tecnológico BioMimic®, Instituto de Ecología A.C. (INECOL), Xalapa 91073, Veracruz, Mexico
4 shared publications - Balasaheb K. Ghotekar
Department of Chemistry, Research Centre HPT Arts and RYK Science College (Affiliated to S. P. Pune Uni-versity), Nashik, 422005, Maharashtra, India, India
4 shared publications
Latest Publications
- Open Access
Design and Evaluation of Indole-Based Schiff Bases as α-Glucosidase Inhibitors: CNN-Enhanced Docking, MD Simulations, ADMET Profiling, and SAR Analysis
Type 2 diabetes mellitus (T2DM) remains a global health challenge, prompting the development of novel α-glucosidase inhibitors (AGIs) to regulate postprandial hyperglycemia. This study reports the design, synthesis, and evaluation of indole-based Schiff base derivatives (4a–j) bearing a fixed methoxy group at the C5 position. This substitution was strategically introduced to enhance lipophilicity, electronic delocalization, and π-stacking within the enzyme active site. Among the series, compound 4g (3-bromophenyl) exhibited the highest inhibitory activity (IC50 = 10.89 µM), outperforming the clinical reference acarbose (IC50 = 48.95 µM). The mechanism was supported by in silico analyses, such as the Density Functional Theory (DFT), molecular electrostatic potential (MEP) mapping, and molecular dynamics simulations, and CNN-based docking revealed that 4g engages in stable hydrogen bonding and π–π interactions with key residues (Asp327, Asp542, and Phe649), suggesting a potent and selective mode of inhibition. In silico ADMET predictions indicated favorable pharmacokinetic properties. Together, these results establish C5–methoxy substitution as a viable strategy to enhance α-glucosidase inhibition in indole-based scaffolds.
Open AccessDesign and Evaluation of Indole-Based Schiff Bases as α-Glucosidase Inhibitors: CNN-Enhanced Docking, MD Simulations, ADMET Profiling, and SAR Analysis
Type 2 diabetes mellitus (T2DM) remains a global health challenge, prompting the development of novel α-glucosidase inhibitors (AGIs) to regulate postprandial hyperglycemia. This study reports the design, synthesis, and evaluation of indole-based Schiff base derivatives (4a–j) bearing a fixed methoxy group at the C5 position. This substitution was strategically introduced to enhance lipophilicity, electronic delocalization, and π-stacking within the enzyme active site. Among the series, compound 4g (3-bromophenyl) exhibited the highest inhibitory activity (IC50 = 10.89 µM), outperforming the clinical reference acarbose (IC50 = 48.95 µM). The mechanism was supported by in silico analyses, such as the Density Functional Theory (DFT), molecular electrostatic potential (MEP) mapping, and molecular dynamics simulations, and CNN-based docking revealed that 4g engages in stable hydrogen bonding and π–π interactions with key residues (Asp327, Asp542, and Phe649), suggesting a potent and selective mode of inhibition. In silico ADMET predictions indicated favorable pharmacokinetic properties. Together, these results establish C5–methoxy substitution as a viable strategy to enhance α-glucosidase inhibition in indole-based scaffolds.
- Open Access
- 6 August 2025
- Published by MDPI AG in Preprints.org
Design and Evaluation of Indole-Based Schiff Bases as α-Glucosidase Inhibitors: CNN-Enhanced Docking, MD Simulations, ADMET Profiling and SAR Analysis
Type 2 diabetes mellitus (T2DM) remains a global health challenge, prompting the development of novel α-glucosidase inhibitors (AGIs) to regulate postprandial hyperglycemia. This study reports the design, synthesis, and evaluation of indole-based Schiff base derivatives (4a–4j) bearing a fixed methoxy group at the C5 position. This substitution was strategically introduced to enhance lipophilicity, electronic delocalization, and π-stacking within the enzyme active site. Among the series, compound 4g (3-bromophenyl) exhibited the highest inhibitory activity (IC50 = 10.89 µM), outperforming the clinical reference acarbose (IC50 = 48.95 µM). Mechanistic support from Density Functional Theory (DFT), molecular electrostatic potential (MEP) mapping, molecular dynamics simulations, and CNN-based docking revealed that 4g engages in stable hydrogen bonding and π–π interactions with key residues (Asp327, Asp542, Phe649). In silico ADMET predictions indicated favorable pharmacokinetic properties. Together, these results establish C5–methoxy substitution as a viable strategy to enhance α-glucosidase inhibition in indole-based scaffolds.
- 6 August 2025
- Published by MDPI AG in Preprints.org
Open AccessDesign and Evaluation of Indole-Based Schiff Bases as α-Glucosidase Inhibitors: CNN-Enhanced Docking, MD Simulations, ADMET Profiling and SAR Analysis
Type 2 diabetes mellitus (T2DM) remains a global health challenge, prompting the development of novel α-glucosidase inhibitors (AGIs) to regulate postprandial hyperglycemia. This study reports the design, synthesis, and evaluation of indole-based Schiff base derivatives (4a–4j) bearing a fixed methoxy group at the C5 position. This substitution was strategically introduced to enhance lipophilicity, electronic delocalization, and π-stacking within the enzyme active site. Among the series, compound 4g (3-bromophenyl) exhibited the highest inhibitory activity (IC50 = 10.89 µM), outperforming the clinical reference acarbose (IC50 = 48.95 µM). Mechanistic support from Density Functional Theory (DFT), molecular electrostatic potential (MEP) mapping, molecular dynamics simulations, and CNN-based docking revealed that 4g engages in stable hydrogen bonding and π–π interactions with key residues (Asp327, Asp542, Phe649). In silico ADMET predictions indicated favorable pharmacokinetic properties. Together, these results establish C5–methoxy substitution as a viable strategy to enhance α-glucosidase inhibition in indole-based scaffolds.
- Open Access
Iodinated Salicylhydrazone Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Enzymatic Activity, Molecular Modeling, and ADMET Profiling
Type 2 diabetes mellitus (T2DM) demands safer and more effective therapies to control postprandial hyperglycemia. Here, we report the synthesis and in vitro evaluation of ten salicylic acid-derived Schiff base derivatives (4a–4j) as α-glucosidase inhibitors. Compounds 4e, 4g, 4i, and 4j exhibited potent enzyme inhibition, with IC50 values ranging from 14.86 to 18.05 µM—substantially better than acarbose (IC50 = 45.78 µM). Molecular docking and 500 ns molecular dynamics simulations revealed stable enzyme–ligand complexes driven by π–π stacking, halogen bonding, and hydrophobic interactions. Density Functional Theory (DFT) calculations and molecular electrostatic potential (MEP) maps highlighted key electronic factors, while ADMET analysis confirmed favorable drug-like properties and reduced nephrotoxicity. Structure–activity relationship (SAR) analysis emphasized the importance of halogenation and aromaticity in enhancing bioactivity.
Open AccessIodinated Salicylhydrazone Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Enzymatic Activity, Molecular Modeling, and ADMET Profiling
Type 2 diabetes mellitus (T2DM) demands safer and more effective therapies to control postprandial hyperglycemia. Here, we report the synthesis and in vitro evaluation of ten salicylic acid-derived Schiff base derivatives (4a–4j) as α-glucosidase inhibitors. Compounds 4e, 4g, 4i, and 4j exhibited potent enzyme inhibition, with IC50 values ranging from 14.86 to 18.05 µM—substantially better than acarbose (IC50 = 45.78 µM). Molecular docking and 500 ns molecular dynamics simulations revealed stable enzyme–ligand complexes driven by π–π stacking, halogen bonding, and hydrophobic interactions. Density Functional Theory (DFT) calculations and molecular electrostatic potential (MEP) maps highlighted key electronic factors, while ADMET analysis confirmed favorable drug-like properties and reduced nephrotoxicity. Structure–activity relationship (SAR) analysis emphasized the importance of halogenation and aromaticity in enhancing bioactivity.
- Open Access
- 12 June 2025
- Published by MDPI AG in Preprints.org
Iodinated Salicylhydrazone Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Enzymatic Activity, Molecular Modeling, and ADMET Profiling
Type 2 diabetes mellitus (T2DM) demands safer and more effective therapies to control postprandial hyperglycemia. Here, we report the synthesis and in vitro evaluation of ten salicylic acid-derived Schiff base derivatives (4a–4j) as α-glucosidase inhibitors. Compounds 4e, 4g, 4i, and 4j exhibited potent enzyme inhibition, with IC50 values ranging from 14.86 to 18.05 µM—substantially better than Acarbose (IC50 = 45.78 µM). Molecular docking and 500 ns molecular dynamics simulations revealed stable enzyme–ligand complexes driven by π–π stacking, halogen bonding, and hydrophobic interactions. Density Functional Theory (DFT) calculations and Molecular Electrostatic Potential (MEP) maps highlighted key electronic factors, while ADMET analysis confirmed favorable drug-like properties and reduced nephrotoxicity. Structure–activity relationship (SAR) analysis emphasized the importance of halogenation and aromaticity in enhancing bioactivity.
- 12 June 2025
- Published by MDPI AG in Preprints.org
Open AccessIodinated Salicylhydrazone Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Enzymatic Activity, Molecular Modeling, and ADMET Profiling
Type 2 diabetes mellitus (T2DM) demands safer and more effective therapies to control postprandial hyperglycemia. Here, we report the synthesis and in vitro evaluation of ten salicylic acid-derived Schiff base derivatives (4a–4j) as α-glucosidase inhibitors. Compounds 4e, 4g, 4i, and 4j exhibited potent enzyme inhibition, with IC50 values ranging from 14.86 to 18.05 µM—substantially better than Acarbose (IC50 = 45.78 µM). Molecular docking and 500 ns molecular dynamics simulations revealed stable enzyme–ligand complexes driven by π–π stacking, halogen bonding, and hydrophobic interactions. Density Functional Theory (DFT) calculations and Molecular Electrostatic Potential (MEP) maps highlighted key electronic factors, while ADMET analysis confirmed favorable drug-like properties and reduced nephrotoxicity. Structure–activity relationship (SAR) analysis emphasized the importance of halogenation and aromaticity in enhancing bioactivity.
- Open Access
- 30 June 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Design, Molecular Docking and Synthesis of Pyrazole-Oxadiazole in search of potent insecticidal agents
A series of sixteen substituted pyrazole oxadiazole derivatives are designed, synthesised and characterized by 1H NMR, 13C NMR and mass spectrometry. The ligands have been docked with Acetylcholine receptor to understand the binding efficiency and amino acids interactions, indicative of all of the sixteen molecules bind efficiently better than Fipronil and Pyrafluprole. These compounds will provide a lead for designing new compounds with improved insecticidal activity.
- 30 June 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDesign, Molecular Docking and Synthesis of Pyrazole-Oxadiazole in search of potent insecticidal agents
A series of sixteen substituted pyrazole oxadiazole derivatives are designed, synthesised and characterized by 1H NMR, 13C NMR and mass spectrometry. The ligands have been docked with Acetylcholine receptor to understand the binding efficiency and amino acids interactions, indicative of all of the sixteen molecules bind efficiently better than Fipronil and Pyrafluprole. These compounds will provide a lead for designing new compounds with improved insecticidal activity.
- 11 March 2023
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (6) , 976-986
An efficient synthesis of new 3,5‐bis(2‐arylthiazol‐4‐yl)‐1,2,4‐oxadiazole derivatives and their antimicrobial evaluation
A new series of 3,5‐bis(2‐arylthiazol‐4‐yl)‐1,2,4‐oxadiazole (8a–o) has been synthesized by modified reaction conditions. The reaction of ester 7a with N′‐hydroxy‐2‐phenylthiazole‐4‐carboximidamide 6a using NaOH in DMSO gave the formation of product 8a up to 40% yield. In the second method, the reaction with K2CO3 in toluene at reflux conditions gave a 50% yield. In the third method, the reaction condition was modified. The ester 7a was hydrolyzed to acid 9a. The reactions of acid 9a using N,N‐dimethyl amino pyridine (DMAP) in N,N‐dimethylformamide (DMF), followed by the addition of N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide hydrochloride (EDC·HCl), and then N′‐hydroxy‐2‐phenylthiazole‐4‐carboximidamide 6a, furnished a 65% yield of 8a. The compounds 8b–o were synthesized using DMAP and EDC·HCl as coupling reagents and gave 60%–72% yields. The structure of newly synthesized compounds was confirmed by spectral analysis. The synthesized compounds were screened for in vitro antimicrobial activity against Escherichia coli (NCIM 2574), Proteus mirabilis (NCIM 2388), Bacillus subtilis (NCIM2063), Staphylococcus albus (NCIM 2178), Candida albicans (NCIM 3100), and Aspergillus niger (ATCC 504). Among the 8a–o derivatives, eight compounds 8c, 8e, 8f, 8g, 8i, 8j, 8k, and 8l showed good activity S. albus with a MIC 31.25–62.5 μg/mL.
- 11 March 2023
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (6) , 976-986
An efficient synthesis of new 3,5‐bis(2‐arylthiazol‐4‐yl)‐1,2,4‐oxadiazole derivatives and their antimicrobial evaluation
A new series of 3,5‐bis(2‐arylthiazol‐4‐yl)‐1,2,4‐oxadiazole (8a–o) has been synthesized by modified reaction conditions. The reaction of ester 7a with N′‐hydroxy‐2‐phenylthiazole‐4‐carboximidamide 6a using NaOH in DMSO gave the formation of product 8a up to 40% yield. In the second method, the reaction with K2CO3 in toluene at reflux conditions gave a 50% yield. In the third method, the reaction condition was modified. The ester 7a was hydrolyzed to acid 9a. The reactions of acid 9a using N,N‐dimethyl amino pyridine (DMAP) in N,N‐dimethylformamide (DMF), followed by the addition of N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide hydrochloride (EDC·HCl), and then N′‐hydroxy‐2‐phenylthiazole‐4‐carboximidamide 6a, furnished a 65% yield of 8a. The compounds 8b–o were synthesized using DMAP and EDC·HCl as coupling reagents and gave 60%–72% yields. The structure of newly synthesized compounds was confirmed by spectral analysis. The synthesized compounds were screened for in vitro antimicrobial activity against Escherichia coli (NCIM 2574), Proteus mirabilis (NCIM 2388), Bacillus subtilis (NCIM2063), Staphylococcus albus (NCIM 2178), Candida albicans (NCIM 3100), and Aspergillus niger (ATCC 504). Among the 8a–o derivatives, eight compounds 8c, 8e, 8f, 8g, 8i, 8j, 8k, and 8l showed good activity S. albus with a MIC 31.25–62.5 μg/mL.
- 21 July 2021
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 31 (12) , 4670-4683
A Highly Selective and Sensitive H2S Gas Sensor Based on Novel Nanostructure Core–Shell FeCr2O4@ZnO@MgO
- 21 July 2021
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 31 (12) , 4670-4683
A Highly Selective and Sensitive H2S Gas Sensor Based on Novel Nanostructure Core–Shell FeCr2O4@ZnO@MgO
- 4 June 2021
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 58 (9) , 1867-1877
Synthesis and biological evaluation of novel 4‐(6‐substituted quinolin‐4‐yl)‐N‐aryl thiazol‐2‐amine derivatives as potential antimicrobial agents
- 4 June 2021
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 58 (9) , 1867-1877
Synthesis and biological evaluation of novel 4‐(6‐substituted quinolin‐4‐yl)‐N‐aryl thiazol‐2‐amine derivatives as potential antimicrobial agents
- 24 July 2020
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 57 (11) , 3918-3929
Synthesis and antimycobacterial screening of new 4‐(4‐(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline derivatives
A new series of 4‐(4‐(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline (6a‐t) have been synthesized by a click reaction of 4‐(4‐ethynyl‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline (4a‐d) with a substituted benzyl azide (5a‐e). The starting alkyne derivatives 4a‐d are obtained from Bestmann‐Ohira reaction of 1‐phenyl‐3‐(quinolin‐4‐yl)‐1H‐pyrazole‐4‐carbaldehyde and dimethyl(1‐diazo‐2‐oxopropyl)phosphonate. The newly synthesized compounds are screened against M. tuberculosis H37Ra dormant and active, Escherichia coli, Pseudomonas fluorescence, Staphylococcus aureus and Bacillus subtilis strains at 30 μg/mL concentration. Most of the screened compounds showed good to moderate antibacterial activity against S. aureus, B. subtilis, and Mycobacterium tuberculosis H37Ra strains. The synthesized derivatives of quinolinyl‐pyrazole‐4‐carbaldehyde and quinolinyl‐pyrazole‐4‐ethyne reportd good to moderate activity against both strains of M. tuberculosis H37Ra. Ten derivatives of quinolinyl‐pyrazole presented good activity against B. subtilis. These results suggested that further optimization and development of quinolinyl‐pyrazolyl‐1,2,3‐triazole moeity could serve as lead compounds for antimycobacterial activity.
- 24 July 2020
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 57 (11) , 3918-3929
Synthesis and antimycobacterial screening of new 4‐(4‐(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline derivatives
A new series of 4‐(4‐(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline (6a‐t) have been synthesized by a click reaction of 4‐(4‐ethynyl‐1‐phenyl‐1H‐pyrazol‐3‐yl)quinoline (4a‐d) with a substituted benzyl azide (5a‐e). The starting alkyne derivatives 4a‐d are obtained from Bestmann‐Ohira reaction of 1‐phenyl‐3‐(quinolin‐4‐yl)‐1H‐pyrazole‐4‐carbaldehyde and dimethyl(1‐diazo‐2‐oxopropyl)phosphonate. The newly synthesized compounds are screened against M. tuberculosis H37Ra dormant and active, Escherichia coli, Pseudomonas fluorescence, Staphylococcus aureus and Bacillus subtilis strains at 30 μg/mL concentration. Most of the screened compounds showed good to moderate antibacterial activity against S. aureus, B. subtilis, and Mycobacterium tuberculosis H37Ra strains. The synthesized derivatives of quinolinyl‐pyrazole‐4‐carbaldehyde and quinolinyl‐pyrazole‐4‐ethyne reportd good to moderate activity against both strains of M. tuberculosis H37Ra. Ten derivatives of quinolinyl‐pyrazole presented good activity against B. subtilis. These results suggested that further optimization and development of quinolinyl‐pyrazolyl‐1,2,3‐triazole moeity could serve as lead compounds for antimycobacterial activity.
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 179, 649-659
Synthesis of new thiazolyl-pyrazolyl-1,2,3-triazole derivatives as potential antimicrobial agents
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 179, 649-659
Synthesis of new thiazolyl-pyrazolyl-1,2,3-triazole derivatives as potential antimicrobial agents